Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials

Smolen et al. https://t.co/hvc5ebX37D The most discriminatory ACR response rate and % improvement in disease activity measures were higher in head-to-head active comparator trials in early RA versus placebo-controlled trials in established RA #rheum